As opposed to the classic oncogenic drivers in naïve NSCLC tumors, they frequently harbor uncommon 5’ partners, such as NCOA4 for RET fusion or CCDC6 for ALK fusions, with unusual breakpoints. The gene discussed is RET; the disease is non-small cell lung carcinoma.